Search results
Amgen/AstraZeneca Say Asthma Drug Shows Activity In Another Lung Disease Across Broad Patient...
Benzinga via Yahoo Finance· 6 days agoSunday, Amgen Inc (NASDAQ:AMGN) and AstraZeneca Plc (NASDAQ:AZN) announced the results of the Phase...
Here's Why We Think AstraZeneca (LON:AZN) Is Well Worth Watching
Simply Wall St. via Yahoo Finance· 3 days agoIf this kind of company isn't your style, you like companies that generate revenue, and even earn...
Pfizer Wins $107.5M Verdict Against AstraZeneca Over Cancer Drug Patent Dispute
Benzinga via Yahoo Finance· 6 days agoA Delaware federal jury has determined that AstraZeneca Plc (NASDAQ:AZN) must pay Pfizer Inc...
AstraZeneca Targets $80 Billion Revenue by 2030 Through Pipeline Expansion
The Wall Street Journal· 6 days agoAstraZeneca has set out a new revenue target as it aims to bolster its investment in technologies...
AstraZeneca (AZN) to Build $1.5B Cancer Drug Plant in Singapore
Zacks via Yahoo Finance· 7 days agoThis new plant will be AstraZeneca's (AZN) first manufacturing facility for producing novel antibody...
AstraZeneca Targets Ambitious $80B In Total Revenue By 2030 Through Pipeline Expansion Why Is ...
Benzinga· 6 days agoTuesday, AstraZeneca Plc AZN announced its ambitious plan to increase its total revenue to $80...
AstraZeneca kicks off ‘new era of growth’ with $80 billion sales goal by 2030
Market Watch· 6 days agoThe Anglo-Swedish pharmaceutical company’s CEO Pascal Soriot said the announcement marks the start...
Pharma Stock Roundup: AZN's 2030 Sales Target, PFE's New Cost Cut Plan & More
Zacks via Yahoo Finance· 3 days agoAstraZeneca (AZN) announces an ambitious target of achieving $80 billion in revenues by 2030. Pfizer...
AstraZeneca aims for $80 billion in total revenue by 2030
Reuters via AOL· 6 days agoAstraZeneca aims to grow revenue by about 75% to $80 billion by 2030, it said on Tuesday, boosted by...
Misleading Claims on Well-Known Rare Risk of AstraZeneca COVID-19 Vaccine - FactCheck.org
FactCheck.org· 3 days agoA rare risk of dangerous blood clots associated with the AstraZeneca COVID-19 vaccine was identified and reported in early 2021. This month, the company announced it was pulling ...